HUMAN KIDNEY 11-BETA-HYDROXYSTEROID DEHYDROGENASE IS A HIGH-AFFINITY NICOTINAMIDE ADENINE DINUCLEOTIDE-DEPENDENT ENZYME AND DIFFERS FROM THE CLONED TYPE-I ISOFORM

被引:191
作者
STEWART, PM
MURRY, BA
MASON, JI
机构
[1] UNIV TEXAS, SW MED CTR, DEPT OBSTET & GYNECOL, CECIL H & IDA GREEN CTR REPROD BIOL SCI, DALLAS, TX 75235 USA
[2] UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, CECIL H & IDA GREEN CTR REPROD BIOL SCI, DALLAS, TX 75235 USA
关键词
D O I
10.1210/jc.79.2.480
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
11 beta-Hydroxysteroid dehydrogenase (11 beta HSD) catalyzes the conversion of cortisol to cortisone and plays an important role in the mammalian kidney in regulating cortisol access to the mineralocorticoid receptor. 11 beta HSD-deficient states, such as the syndrome of apparent mineralocorticoid excess (AME), and licorice ingestion result in hypertension in which cortisol acts as a mineralocorticoid. A gene and complementary DNA sequence encoding type I human 11 beta HSD have been described, but this gene is normal in patients with AME. Separate 11 beta HSD isoforms have been described in rat and rabbit kidney, but 11 beta HSD has not been characterized in human kidney. Kinetic analysis of 11 beta HSD activity in human fetal kidney microsomes revealed only a high affinity isoform (apparent K-m, 60 nmol/L for cortisol, 13 nmol/L for corticosterone), the activity of which was exclusively nicotinamide adenine dinucleotide (NAD) dependent. No 11-oxo-reductase activity was seen in either renal homogenates or microsomes. 11 beta-Dehydrogenase activity was inhibited by glycyrrhetinic acid (the active ingredient in licorice) in a competitive fashion, with a K-i of 8.7 nmol/L. This 11 beta HSD isoform was clearly distinct from the type I h11 beta HSD enzyme, in that COS-1 cells transfected with type I h11 beta HSD complementary DNA expressed a low affinity (apparent K-m, 2.13 mu mol/L) isoform, the activity of which was NAD phosphate dependent, 11-Oxo-reductase activity was present in intact transfected cells (apparent K-m for cortisone, 0.36 mu mol/L), but not in cell lysates. In contrast to the cloned, low affinity, type I h11 beta HSD enzyme, human kidney contains a high affinity NAD-deDendent 11 beta HSD isoform. It seems probable that this isoform is responsible for protecting the renal mineralocorticoid receptor from glucocorticoid excess, and a defect in its activity may explain AME.
引用
收藏
页码:480 / 484
页数:5
相关论文
共 30 条
  • [1] AGARWAL AK, 1989, J BIOL CHEM, V264, P18939
  • [2] AGRAWAL AK, 1990, MOL ENDOCRINOL, V4, P1827
  • [3] CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR
    ARRIZA, JL
    WEINBERGER, C
    CERELLI, G
    GLASER, TM
    HANDELIN, BL
    HOUSMAN, DE
    EVANS, RM
    [J]. SCIENCE, 1987, 237 (4812) : 268 - 275
  • [4] BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] HUMAN PLACENTAL 11-BETA-HYDROXYSTEROID DEHYDROGENASE - EVIDENCE FOR AND PARTIAL-PURIFICATION OF A DISTINCT NAD-DEPENDENT ISOFORM
    BROWN, RW
    CHAPMAN, KE
    EDWARDS, CRW
    SECKL, JR
    [J]. ENDOCRINOLOGY, 1993, 132 (06) : 2614 - 2621
  • [7] NEW FINDINGS IN APPARENT MINERALOCORTICOID EXCESS
    DIMARTINONARDI, J
    STONER, E
    MARTIN, K
    BALFE, JW
    JOSE, PA
    NEW, MI
    [J]. CLINICAL ENDOCRINOLOGY, 1987, 27 (01) : 49 - 62
  • [8] LOCALIZATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR
    EDWARDS, CRW
    BURT, D
    MCINTYRE, MA
    DEKLOET, ER
    STEWART, PM
    BRETT, L
    SUTANTO, WS
    MONDER, C
    [J]. LANCET, 1988, 2 (8618) : 986 - 989
  • [9] MINERALOCORTICOID ACTION - TARGET TISSUE-SPECIFICITY IS ENZYME, NOT RECEPTOR, MEDIATED
    FUNDER, JW
    PEARCE, PT
    SMITH, R
    SMITH, AI
    [J]. SCIENCE, 1988, 242 (4878) : 583 - 585
  • [10] RENAL CAPTURE AND OXIDATION OF CORTISOL IN MAN
    HELLMAN, L
    NAKADA, F
    ZUMOFF, B
    FUKUSHIMA, D
    BRADLOW, HL
    GALLAGHER, TF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 33 (01) : 52 - +